Rhumbline Advisers Sells 1,318 Shares of Blueprint Medicines Co. (NASDAQ:BPMC)
Rhumbline Advisers trimmed its holdings in shares of Blueprint Medicines Co. (NASDAQ:BPMC – Free Report) by 1.5% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 86,531 shares of the biotechnology company’s stock after selling 1,318 shares during the period. Rhumbline Advisers’ holdings […]
Rhumbline Advisers trimmed its holdings in shares of Blueprint Medicines Co. (NASDAQ:BPMC – Free Report) by 1.5% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 86,531 shares of the biotechnology company’s stock after selling 1,318 shares during the period. Rhumbline Advisers’ holdings […]
